Varma Rudraraju has Completed his B.S. In Pharmacy from Andhra University, India and MS and Ph.D. in Pharmaceutics from University Of Mississippi (Ole Miss), USA. He is a member of Rho Chi, Sigma Xi and Dean’s honor roll at Ole Miss. Worked for over 14 years in USA at Syntex Research, Solvay Pharmaceuticals, Dupont-Merck, Bristol Myers Squibb and Roche in various technical and administrative roles. Played a key role in introducing products like Toradol®, Naproxen EC, Cellcept®, Sustiva®, Copegus® etc. into the global market.

Experience ranges from pre-formulation thru commercial manufacturing including clinical development of various dosage forms for global filing. Multiple publications and poster presentations in peer reviewed journals. Research interests are in the areas of characterization of excipients and developing poorly soluble drugs having low permeability. Global technical champion and board member for process analytical technologies (PAT) and consortium for advanced development and manufacturing practices (CAMP) in USA. Invited speaker at various scientific meetings and by the food & drug administration (FDA) to train their chemists and investigators in drug development and manufacturing. Varma is the Chairman and CEO Of Aizant drug research which is a R&D based organization providing drug development, clinical development and pre-clinical services to clients across the globe.